Ascendis Health Limited (ASC.JO)

ZAc 78.0

(0.0%)

Market Cap (In ZAc)

488.08 Million

Revenue (In ZAc)

1.47 Billion

Net Income (In ZAc)

41.57 Million

Avg. Volume

1.2 Million

Currency
ZAc
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
63.0-82.0
PE
-
EPS
-
Beta Value
0.666
ISIN
ZAE000185005
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. A. Carl Neethling
Employee Count
-
Website
https://www.ascendishealth.com
Ipo Date
2013-11-22
Details
Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Hungary, Romania, and internationally. The company operates through Consumer Health, Pharma, and Medical segments. It offers body and skin products; and natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Nimue, Scitec, Solal, and Vitaforce brand names. The company also provides medical devices, and diagnostic laboratory equipment and consumables for operating theatres, ICUs, trauma units, maternity and general wards, radiology, pathology labs, research and science institutes, etc.; generic pharmaceutical products, antineoplastic agents, antivirals, aromatase inhibitors, anti-infectives; and products for the nervous system, cardiovascular system, dermatological products, and antimalarials, as well as other therapeutic products under the Pharmachem, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, and The Scientific Group brands. In addition, it exports its products. The company serves pharmacies, retailers, beauticians, and doctors. Ascendis Health Limited was incorporated in 2008 and is based in Johannesburg, South Africa.